MAY 20, 2020
Biophytis second AGM to take place on May 28, 2020 without the physical presence of its shareholders. Read the Press Release
MAY 20, 2020
Biophytis Receives Approval from the Belgian Regulatory Agency (FAMHP) to Initiate COVA, a Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID19 Related Respiratory Failure. Read the Press Release